Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes.

Risa TsunematsuAiko MuraiYuka MizueTerufumi KuboTasuku MariyaRena MoritaKenji MurataTakayuki KanasekiTomohide TsukaharaYoshihiko HirohashiTsuyoshi SaitoToshihiko Torigoe

Published in: Cancer genomics & proteomics (2024)

Cancer immunotherapy is an effective approach to target ARID1A-deficient clear cell carcinoma of the ovary.

Keyphrases

clear cell
binding protein
wild type